MCID: MSC007
MIFTS: 52

Muscle Hypertrophy malady

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for Muscle Hypertrophy

About this section

Aliases & Descriptions for Muscle Hypertrophy:

Name: Muscle Hypertrophy 49 11 67
Muscle Hypertrophy Syndrome 24
 
Mslhp 67

Characteristics:

HPO:

61
muscle hypertrophy:
Inheritance: autosomal recessive inheritance


Classifications:



External Ids:

OMIM49 614160
MedGen34 CN069079

Summaries for Muscle Hypertrophy

About this section
UniProtKB/Swiss-Prot:67 Muscle hypertrophy: A condition characterized by increased muscle bulk and strength. Affected individuals are exceptionally strong.

MalaCards based summary: Muscle Hypertrophy, also known as muscle hypertrophy syndrome, is related to myostatin-related muscle hypertrophy and kummell's disease, and has symptoms including skeletal muscle hypertrophy An important gene associated with Muscle Hypertrophy is MSTN (Myostatin), and among its related pathways are EGFR Transactivation by Gastrin and LKB1 signaling events. Affiliated tissues include skeletal muscle, heart and prostate, and related mouse phenotypes are renal/urinary system and normal.

Wikipedia:68 Muscle hypertrophy involves an increase in size of skeletal muscle through a growth in size of its... more...

Description from OMIM:49 614160

Related Diseases for Muscle Hypertrophy

About this section

Graphical network of the top 20 diseases related to Muscle Hypertrophy:



Diseases related to muscle hypertrophy

Symptoms for Muscle Hypertrophy

About this section


Clinical features from OMIM:

614160

HPO human phenotypes related to Muscle Hypertrophy:

id Description Frequency HPO Source Accession
1 skeletal muscle hypertrophy HP:0003712

Drugs & Therapeutics for Muscle Hypertrophy

About this section

Drugs for Muscle Hypertrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 169)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Gemifloxacinapproved, investigationalPhase 44175463-14-65464436, 9571107
Synonyms:
175463-14-6
204519-64-2
210353-52-9
210353-53-0
210353-55-2
210353-56-3
214346-11-9
7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
BRD-A40787240-066-02-0
BSPBio_002308
CHEBI:101853
CHEMBL430
CID9571107
D08012
 
Factiv
Factiv (TN)
Factive
Gemifloxacin
Gemifloxacin (INN)
Gemifloxacin [INN]
Gemifloxacin mesilate
Gemifloxacin mesylate
LB 20304
LB 20304a
LB-20304
LS-186992
LS-187779
NCGC00178711-01
SB 265805
SB-265805
gemifloxacin mesylate
2
AllopurinolapprovedPhase 4129315-30-02094
Synonyms:
1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one
1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one
184856-42-6
1H-Pyrazolo(3,4-D)pyrimidin-4-ol
22767-92-6
315-30-0
39464-14-7
4'-Hydroxypyrazolol(3,4-D)pyrimidine
4-HPP
4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine
4-Hydroxy-3,4-pyrazolopyrimidine
4-Hydroxypyrazolo(3,4-D)pyrimidine
4-Hydroxypyrazolopyrimidine
4-Hydroxypyrazolyl(3,4-D)pyrimidine
4H-Pyrazolo(3,4-D)pyrimidin-4-one
7HP
A 8003
A0907
A8003_SIGMA
AC-019
AC1L1CWL
AC1Q6FWV
AC1Q6GP7
AKOS000267490
AKOS000269759
AL-100
Adenock
Ailural
Ailurial
Allo-Puren
Allohexal
Allohexan
Alloprin
Allopur
Allopurin
Allopurinol
Allopurinol Sodium
Allopurinol(I)
Allopurinolum
Allopurinolum [INN-Latin]
Allorin
Allozym
Allpargin
Allural
Aloprim
Alopurinol
Alopurinol [INN-Spanish]
Aloral
Alositol
Aluline
Anoprolin
Anzief
Apo-Allopurinol
Apulonga
Apurin
Apurol
Atisuril
B. W. 56-158
BB_SC-5394
BIM-0061756.0001
BSPBio_001798
BW 56-158
BW 56158
BW-56-158
Bio-0799
Bleminol
Bloxanth
C5H4N4O
CCRIS 626
CHEBI:40279
CHEBI:495607
CHEMBL1467
CID2094
CPD-9024
CPD000059083
Caplenal
Capurate
Cellidrin
Cosuric
D000493
DB00437
Dabrosin
Dabroson
DivK1c_000685
Dura Al
EINECS 206-250-9
EN000932
EU-0100102
Embarin
Epidropal
Epuric
Foligan
Geapur
Gichtex
Gotax
HMS1920A15
HMS2091G15
HMS502C07
HPP
 
HSDB 3004
Hamarin
Hexanuret
I03-0052
IDI1_000685
Jenapurinol
Jsp005881
KBio1_000685
KBio2_000386
KBio2_002954
KBio2_005522
KBio3_001298
KBioGR_000550
KBioSS_000386
Ketanrift
Ketobun-A
LS-1180
Ledopur
Lopac-A-8003
Lopac0_000102
Lopurin
Lysuron
MLS000069453
MLS001148183
Milurit
Milurite
Miniplanor
MolPort-000-141-383
MolPort-000-870-337
MolPort-004-758-159
MolPort-004-758-166
MolPort-004-758-167
MolPort-004-758-643
Monarch
NCGC00015094-01
NCGC00015094-03
NCGC00015094-06
NCGC00091134-01
NCGC00091134-02
NCGC00091134-03
NCGC00094580-01
NCGC00094580-02
NCIOpen2_001825
NINDS_000685
NSC 101655
NSC 1390
NSC-1390
NSC101655
NSC1390
Nektrohan
Novopurol
Pan Quimica
Prestwick_511
Progout
Pureduct
Purinol
Quimica, Pan
Remid
Riball
Rimapurinol
Roucol
S1630_Selleck
SAM002554884
SMR000059083
SPBio_000056
SPECTRUM1500108
STK378584
STK711106
Sigapurol
Spectrum2_000098
Spectrum3_000289
Spectrum4_000135
Spectrum5_000768
Spectrum_000026
Suspendol
Takanarumin
Tipuric
UNII-63CZ7GJN5I
Urbol
Uribenz
Uricemil
Uridocid
Uriprim
Uripurinol
Uritas
Urobenyl
Urolit
Urosin
Urtias
Urtias 100
Xanthomax
Xanturat
Xanturic
Zygout
Zyloprim
Zyloprim (tn)
Zyloric
allopurinol
nchembio.92-comp3
nchembio732-comp4
3
AzithromycinapprovedPhase 432283905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
4
AtracuriumapprovedPhase 46564228-79-147319
Synonyms:
1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
64228-79-1
64228-81-5 (besylate)
AB00514743
AC1L2HUF
AC1Q67HR
ATRACURIUM
Atracurium
Atracurium Dibesylate
BPBio1_000011
BRN 1523633
 
BSPBio_000009
C07548
C53H70N2O12
CHEBI:2914
CHEMBL1360
CID47319
DB00732
HMS2090I21
LS-86151
MolPort-005-932-641
Prestwick1_000005
Prestwick2_000005
Prestwick3_000005
SPBio_001930
UNII-2GQ1IRY63P
5
MivacuriumapprovedPhase 48106791-40-65281042
Synonyms:
(R)-1,2,3,4-Tetrahydro-2-(3-hydroxypropyl)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium chloride, (E)-4-octenedioate (2:1)
106791-40-6
106861-44-3
133814-19-4
AC1NQXXZ
AC1NQXZZ
BW B109OU dichloride
BW-B1090U
BW-B109OU
BWB109OU
C07550
C58H80N2O14
CHEMBL984
CID5281042
CID5281080
Chlorure de mivacurium
Chlorure de mivacurium [French]
 
Cloruro de mivacurio
Cloruro de mivacurio [Spanish]
D00763
DB01226
LS-172022
MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
MIVACURIUM CHLORIDE
Mivacron
Mivacron (TN)
Mivacurii chloridum
Mivacurii chloridum [Latin]
Mivacurium
Mivacurium chloride (USAN/INN)
Mivacurium chloride [USAN:INN:BAN]
NCGC00167469-01
SID50112723
bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate
bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate dichloride
6
RocuroniumapprovedPhase 4238119302-91-9, 143558-00-3441290
Synonyms:
(2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane
143558-00-3
AC1L9AWM
BIDD:GT0360
C07556
CHEBI:8884
CID441290
DB00728
 
Esmeron
HMS2090E03
NCGC00167433-01
Rocuronium
Rocuronium Bromide
Rocuronium bromide
SID50112687
Zemuron
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
7
MetforminapprovedPhase 41645657-24-9, 1115-70-414219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMBG
DMGG
Diabefagos
Diabetosan
Diabex
Diaformin
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Meguan
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin Hydrochloride
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
Obimet
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
8
LidocaineapprovedPhase 41103137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
9
MethylprednisoloneapprovedPhase 4108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
10
PrednisoloneapprovedPhase 4108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
11
Telmisartanapproved, investigationalPhase 4260144701-48-465999
Synonyms:
144701-48-4
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
AC-2013
AC1L24EB
AC1Q5U7O
Abbott brand of telmisartan
BAY-68-9291
BAY68-9291
BIBR 277
BIBR 277SE
BIBR-277
BIBR-277-SE
BIBR-277SE
BIDD:GT0365
BRD-K73999723-001-02-2
BSPBio_002738
Bay 68-9291
Bio-0103
Boehringer Ingelheim brand of telmisartan
C07710
C084178
C33H30N4O2
CHEBI:9434
CHEMBL1017
CID65999
CPD000466326
D00627
DB00966
Glaxo Wellcome brand of telmisartan
GlaxoSmithKline brand of telmisartan
 
HMS1922P07
HMS2051P16
HMS2090P17
HMS2093M22
HSDB 7590
I06-0281
KBio3_001958
KBioGR_001842
Kinzal
Kinzalmono
L001035
LS-44263
MLS000759432
MLS001076687
Micardis
Micardis (TN)
Micardis HCT
Micardis, Targit, Temax, BIBR277, Telmisartan
MolPort-003-666-621
NCGC00095150-01
NCGC00095150-02
NCGC00095150-03
Pritor
S1738_Selleck
SAM001246602
SMR000466326
SPBio_002131
SPECTRUM1505261
STK624049
Spectrum2_001976
Spectrum3_001089
Spectrum4_001261
Spectrum5_001053
TL8000991
Telmisartan
Telmisartan (JAN/USAN/INN)
Telmisartan [USAN:INN]
UNII-U5SYW473RQ
YM-086
telmisartan
12
AcetylcholineexperimentalPhase 4, Phase 268951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
13Antihypertensive AgentsPhase 4, Phase 3, Phase 23618
14Angiotensin Receptor AntagonistsPhase 4, Phase 3, Phase 21039
15Anti-Arrhythmia AgentsPhase 4, Phase 3, Phase 22371
16AngiotensinogenPhase 4, Phase 3, Phase 21032
17AntimetabolitesPhase 4, Phase 39454
18Angiotensin II Type 1 Receptor BlockersPhase 4, Phase 3, Phase 2949
19Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 18478
20HormonesPhase 4, Phase 3, Phase 211748
21Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 29988
22Hormone AntagonistsPhase 4, Phase 3, Phase 210002
23Antineoplastic Agents, HormonalPhase 4, Phase 24256
24
Angiotensin IIPhase 4, Phase 3, Phase 2103368521-88-0, 11128-99-7172198, 65143
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
25Anti-Bacterial AgentsPhase 4, Phase 19140
26Anti-Infective AgentsPhase 4, Phase 2, Phase 117220
27Botulinum Toxins, Type APhase 4, Phase 2588
28Cholinergic AgentsPhase 4, Phase 23243
29IncobotulinumtoxinAPhase 4, Phase 2599
30Botulinum ToxinsPhase 4, Phase 2616
31AbobotulinumtoxinAPhase 4, Phase 2588
32AntioxidantsPhase 4, Phase 2, Phase 3, Phase 12442
33Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 18496
34Protective AgentsPhase 4, Phase 2, Phase 3, Phase 15651
35Neurotransmitter AgentsPhase 4, Phase 3, Phase 214795
36Neuromuscular AgentsPhase 4, Phase 2922
37GentamicinsPhase 4123
38OnabotulinumtoxinAPhase 4, Phase 2588
39Topoisomerase InhibitorsPhase 44081
40Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 118510
41Cholinergic AntagonistsPhase 41423
42Neuromuscular Nondepolarizing AgentsPhase 4176
43Hypoglycemic AgentsPhase 44503
44Neuromuscular Blocking AgentsPhase 4327
45AnestheticsPhase 47385
46Neuroprotective AgentsPhase 41376
47Prednisolone acetatePhase 41082
48Prednisolone hemisuccinatePhase 41082
49Prednisolone phosphatePhase 41082
50Central Nervous System DepressantsPhase 410016

Interventional clinical trials:

(show top 50)    (show all 154)
idNameStatusNCT IDPhase
1Efficacy of Combination Therapies for Gonorrhea TreatmentCompletedNCT00926796Phase 4
2Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?CompletedNCT00688480Phase 4
3The SLIM Study: Sling and Botox® Injection for Mixed Urinary IncontinenceRecruitingNCT02678377Phase 4
4Effect of Deep BLock on Intraoperative Surgical ConditionsRecruitingNCT01631149Phase 4
5MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery DiseaseRecruitingNCT02226510Phase 4
6Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED StudyActive, not recruitingNCT01951404Phase 4
7Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided TechniquesNot yet recruitingNCT00992108Phase 4
8Quadripolar Leads for the Management of Heart Failure Patients in the Middle EastNot yet recruitingNCT02195843Phase 4
9Identification of Carnitine-Responsive CardiomyopathyNot yet recruitingNCT01904396Phase 4
10Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye DiseaseNot yet recruitingNCT02339142Phase 4
11SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk PatientsTerminatedNCT00274105Phase 4
12Effects of Kneehab 12-week Peri-operative Total Knee ArthroplastyCompletedNCT01096524Phase 3
13Effectiveness of Creatine Supplementation and Exercise on Muscle and BoneCompletedNCT01057680Phase 3
14Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the HeartCompletedNCT00317967Phase 3
15Running Effect on Cardiovascular and Muscular ParametersCompletedNCT01406730Phase 3
16Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)CompletedNCT00670306Phase 3
17Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan SyndromeCompletedNCT00723801Phase 3
18Anakinra to Prevent Post-infarction RemodelingCompletedNCT00789724Phase 3
19Myocardial Protection With Perhexiline in Left Ventricular HypertrophyRecruitingNCT00989508Phase 2, Phase 3
20H-36731: Finasteride in Management of Elevated Red Blood CellsNot yet recruitingNCT02548117Phase 3
21DMSO for Prevention of Capsular Contraction in Alloplastic Breast ReconstructionNot yet recruitingNCT02206477Phase 2, Phase 3
22The Effect of Neuromuscular Electrical Stimulation (NMES)CompletedNCT00765739Phase 2
23Physical Activity, Calcium, and Bone in ChildrenCompletedNCT00000415Phase 2
24Effect of Exercise on Renal Function in PredialysisCompletedNCT02155036Phase 1, Phase 2
25An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction ChemotherapyCompletedNCT01446081Phase 2
26Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart MuscleCompletedNCT00001960Phase 2
27Study of Blood Flow in Heart MuscleCompletedNCT00001631Phase 2
285-Alpha Reductase and Anabolic Effects of TestosteroneCompletedNCT00475501Phase 2
29Resistance Training in ElderlyCompletedNCT00744094Phase 1, Phase 2
30Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)CompletedNCT00001965Phase 2
31A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic CardiomyopathyCompletedNCT00001894Phase 2
32Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot StudyCompletedNCT00035386Phase 2
33Pirfenidone to Treat Hypertrophic CardiomyopathyCompletedNCT00011076Phase 2
34Effect of Losartan in Patients With Nonobstructive Hypertrophic CardiomyopathyCompletedNCT01150461Phase 2
35Perhexiline Therapy in Patients With Hypertrophic CardiomyopathyCompletedNCT00500552Phase 2
36Study of Oral PG-116800 Following a Heart AttackCompletedNCT00067236Phase 2
37Safety of KAI-9803 for Injection With Angioplasty Following Heart AttackCompletedNCT00093197Phase 1, Phase 2
38Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral TestosteroneCompletedNCT00161421Phase 2
39Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle HypertrophyRecruitingNCT02010775Phase 2
40OptiTrain - Optimal Training Women With Breast CancerRecruitingNCT02522260Phase 1, Phase 2
41Medytoxin® Treatment in Patients With Benign Masseteric HypertrophyRecruitingNCT02292472Phase 2
42Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 GramsRecruitingNCT02396420Phase 2
43Egg Cholesterol Consumption, Blood Cholesterol and Skeletal Muscle HypertrophyActive, not recruitingNCT00260442Phase 2
44"BP as a New Device for Surgery and Solid Cancer and Hematopoietic System Tumors Treatment. Effects of BP Implantation"Active, not recruitingNCT02328352Phase 1, Phase 2
45Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device PlacementActive, not recruitingNCT00869024Phase 1, Phase 2
46Testosterone Plus Finasteride Treatment After Spinal Cord InjuryNot yet recruitingNCT02248701Phase 2
47Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe AsthmaTerminatedNCT01050491Phase 2
48A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar ContracturesTerminatedNCT01564407Phase 1, Phase 2
49Feasibility Study of Radiofrequency Heating of Cardiac Infarction Scar to Treat Heart FailureTerminatedNCT00881777Phase 1, Phase 2
50Secondary Prevention in Type 2 Diabetes: Comparison of Two Different Resistance Exercise Training ProtocolsCompletedNCT01218256Phase 1

Search NIH Clinical Center for Muscle Hypertrophy

Genetic Tests for Muscle Hypertrophy

About this section

Anatomical Context for Muscle Hypertrophy

About this section

MalaCards organs/tissues related to Muscle Hypertrophy:

33
Skeletal muscle, Heart, Prostate, Spinal cord, Breast, Bone, Thyroid

Animal Models for Muscle Hypertrophy or affiliated genes

About this section

MGI Mouse Phenotypes related to Muscle Hypertrophy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.9IGF1, MSTN, MTOR, PPP3CA, SMAD4
2MP:00028738.5FKRP, GATA6, IGF1, MTOR, MYOC, SMAD4
3MP:00053857.7FHL1, GATA6, HEY2, IGF1, MSTN, SMAD4
4MP:00036317.2FHL1, FKRP, HEY2, IGF1, MTOR, PPP3CA
5MP:00107687.0FKRP, GATA6, HEY2, IGF1, MSTN, MTOR
6MP:00053766.4FHL1, FKRP, GATA6, HEY2, IGF1, MSTN
7MP:00053696.4FHL1, FKRP, GATA6, HEY2, IGF1, MSTN
8MP:00053786.4FHL1, FKRP, GATA6, HEY2, IGF1, MSTN

Publications for Muscle Hypertrophy

About this section

Articles related to Muscle Hypertrophy:

(show top 50)    (show all 113)
idTitleAuthorsYear
1
Effect of previous strength training episode and retraining on facilitation of skeletal muscle hypertrophy and contractile properties after long-term detraining in rats. (27162768)
2016
2
Ribosome Biogenesis is Necessary for Skeletal Muscle Hypertrophy. (27135313)
2016
3
AMPKI^3 is dispensable for skeletal muscle hypertrophy induced by functional overload. (26758685)
2016
4
Recurrent parotid swelling secondary to masseter muscle hypertrophy: a multidisciplinary diagnostic and therapeutic approach. (26892838)
2016
5
The effects of resistance exercise on cocaine self-administration, muscle hypertrophy, and BDNF expression in the nucleus accumbens. (27137405)
2016
6
Identification of a Novel Four and a Half LIM Domain 1 Mutation in a Chinese Male Presented with Hypertrophic Cardiomyopathy and Mild Skeletal Muscle Hypertrophy. (26265627)
2015
7
The metabolic and temporal basis of muscle hypertrophy in response to resistance exercise. (26289597)
2015
8
Contribution of muscle hypertrophy to strength gain after training in elderly adults. (26252190)
2015
9
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. (26457176)
2015
10
Role of IGF-I in follistatin-induced skeletal muscle hypertrophy. (26219865)
2015
11
An inability to distinguish edematous swelling from true hypertrophy still prevents a completely accurate interpretation of the time course of muscle hypertrophy. (26515294)
2015
12
Blood flow-restricted walking in older women: does the acute hormonal response associate with muscle hypertrophy? (26517965)
2015
13
Rigid substrate induces esophageal smooth muscle hypertrophy and eosinophilic esophagitis fibrotic gene expression. (26542032)
2015
14
The myokine decorin is regulated by contraction and involved in muscle hypertrophy. (24996176)
2014
15
Bilateral anterior tarsal tunnel syndrome variant secondary to extensor hallucis brevis muscle hypertrophy in a ballet dancer: a case report. (25457672)
2014
16
Bow hunter's syndrome causing vertebrobasilar insufficiency in a young male with neck muscle hypertrophy: a case report and literature review. (24184499)
2013
17
Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2. (22939275)
2013
18
No histological evidence of orbicularis oculi muscle hypertrophy in congenital epiblepharon. (22712518)
2013
19
A PGC-1I+ isoform induced by resistance training regulates skeletal muscle hypertrophy. (23217713)
2012
20
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men. (23127247)
2012
21
Muscle plasticity and I^a88-adrenergic receptors: adaptive responses of I^a88-adrenergic receptor expression to muscle hypertrophy and atrophy. (22190857)
2011
22
Genetic variability in the myostatin gene does not explain the muscle hypertrophy and clinical penetrance in myotonia congenita. (19918890)
2010
23
Muscle hypertrophy and increased expression of leptin receptors in the musculus triceps brachii of the dominant arm in professional tennis players. (20187280)
2010
24
Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. (20023119)
2010
25
Mechano-biology of skeletal muscle hypertrophy and regeneration: possible mechanism of stretch-induced activation of resident myogenic stem cells. (20163667)
2010
26
Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3beta and p70 ribosomal S6 kinase. (20190034)
2010
27
Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3I^. (20525681)
2010
28
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. (19383783)
2009
29
Thermal manipulations in late-term chick embryos have immediate and longer term effects on myoblast proliferation and skeletal muscle hypertrophy. (19023019)
2009
30
Muscle hypertrophy of the lower leg caused by L5 radiculopathy. (19523866)
2009
31
Acute and long-term effects of resistance exercise with or without protein ingestion on muscle hypertrophy and gene expression. (18661258)
2009
32
Peripheral myoclonus and muscle hypertrophy of quadriceps revealing a spinal dysraphism. (19303804)
2009
33
Regulation of mTOR signaling in skeletal muscle hypertrophy. (19147966)
2008
34
PGF2alpha-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN. (18160324)
2008
35
Extraocular muscle hypertrophy in myotonia congenita. (18313341)
2008
36
Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling. (17940216)
2007
37
Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. (16916907)
2006
38
Alterations of M-cadherin, neural cell adhesion molecule and beta-catenin expression in satellite cells during overload-induced skeletal muscle hypertrophy. (16776666)
2006
39
Skeletal muscle hypertrophy and structure and function of skeletal muscle fibres in male body builders. (16339176)
2006
40
Transforming growth factor-beta induces airway smooth muscle hypertrophy. (16239645)
2006
41
Skeletal muscle hypertrophy and atrophy signaling pathways. (16087388)
2005
42
Molecular mechanisms involving IGF-1 and myostatin to induce muscle hypertrophy as a therapeutic strategy for Duchenne muscular dystrophy. (16629058)
2005
43
Myostatin mutation associated with gross muscle hypertrophy in a child. (15215484)
2004
44
Myostatin mutation associated with gross muscle hypertrophy in a child. (15352277)
2004
45
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. (11715023)
2001
46
Primary orthostatic tremor with prominent muscle hypertrophy. (9305357)
1997
47
Myostatin-Related Muscle Hypertrophy (20301671)
1993
48
The extent of muscle hypertrophy in infantile hypertrophic pyloric stenosis does not depend on age and duration of symptoms. (3559857)
1987
49
Papillary muscle hypertrophy in chronic rheumatic mitral valve stenosis. A clinicopathologic study. (7218525)
1981
50
Myokymia, muscle hypertrophy and percussion "myotonia" in chronic recurrent polyneuropathy. (568731)
1978

Variations for Muscle Hypertrophy

About this section

Clinvar genetic disease variations for Muscle Hypertrophy:

5
id Gene Variation Type Significance SNP ID Assembly Location
1NM_005259.2(MSTN): c.458A> G (p.Lys153Arg)single nucleotide variantPathogenicrs1805086GRCh37Chr 2, 190925077: 190925077
2NM_005259.2(MSTN): c.373+5G> Asingle nucleotide variantPathogenicrs397515373GRCh37Chr 2, 190926945: 190926945

Expression for genes affiliated with Muscle Hypertrophy

About this section
Search GEO for disease gene expression data for Muscle Hypertrophy.

Pathways for genes affiliated with Muscle Hypertrophy

About this section

GO Terms for genes affiliated with Muscle Hypertrophy

About this section

Biological processes related to Muscle Hypertrophy according to GeneCards Suite gene sharing:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cholangiocyte apoptotic processGO:190419310.4IGF1, MTOR
2regulation of MAPK cascadeGO:004340810.2MSTN, MYOC
3cardiac muscle tissue developmentGO:004873810.2GATA6, MTOR
4positive regulation of stress fiber assemblyGO:005149610.1MTOR, MYOC
5growthGO:004000710.0MSTN, MTOR
6positive regulation of protein kinase B signalingGO:005189710.0MTOR, MYOC
7positive regulation of smooth muscle cell proliferationGO:00486619.9IGF1, MTOR
8response to heatGO:00094089.8IGF1, MSTN
9positive regulation of cardiac muscle cell proliferationGO:00600459.7GATA6, HEY2
10smooth muscle cell differentiationGO:00511459.7GATA6, HEY2
11cell fate commitmentGO:00451659.6GATA6, HEY2
12cardiac muscle hypertrophy in response to stressGO:00148989.4GATA6, HEY2, PPP3CA
13regulation of gene expressionGO:00104689.3GATA6, HEY2, IGF1
14muscle organ developmentGO:00075179.2FHL1, IGF1, MSTN
15positive regulation of transcription, DNA-templatedGO:00458939.2GATA6, IGF1, MSTN, SMAD4
16negative regulation of transcription, DNA-templatedGO:00458928.5GATA6, HEY2, SMAD4

Sources for Muscle Hypertrophy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet